Fetal therapy: 2020 and beyond

Prenatal Diagnosis

Volumn 30, Issue 7, 2010, Pages 699-701

  Choolani, Mahesh ^a,b   Chan, Jerry ^a,b,c   Fisk, Nicholas M ^d  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NATIONAL UNIVERSITY HOSPITAL   (Singapore)

^c KK WOMEN'S AND CHILDREN'S HOSPITAL   (Singapore)

^d UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Fetal surgery; Gene therapy; Stem cells

Indexed keywords

ALLOTRANSPLANTATION; ANEMIA; CONGENITAL DIAPHRAGM HERNIA; EX VIVO GENE TRANSFER; FETAL THERAPY; FETUS CELL; FETUS SURGERY; GENE THERAPY; HEMATOPOIETIC STEM CELL; HUMAN; INTRAUTERINE BLOOD TRANSFUSION; LASER COAGULATION; MENINGOMYELOCELE; NONHUMAN; PREGNANCY TERMINATION; PRIORITY JOURNAL; REVIEW; STEM CELL; TWIN TWIN TRANSFUSION SYNDROME; FEMALE; FETAL DISEASES; FETOFETAL TRANSFUSION; FETUS; HERNIA, DIAPHRAGMATIC; PREGNANCY; PROCEDURES; STEM CELL TRANSPLANTATION; TRENDS;

FEMALE; FETAL DISEASES; FETAL THERAPIES; FETOFETAL TRANSFUSION; FETUS; GENETIC THERAPY; HERNIA, DIAPHRAGMATIC; HUMANS; MENINGOMYELOCELE; PREGNANCY; STEM CELL TRANSPLANTATION;

EID: 77954093275     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.2527     Document Type: Review

References (48)

1. Aiuti A, Slavin S, Aker M, et al. 2002. Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning. Science 296: 2410-2413.
2. Baek KH, Zaslavsky A, Lynch RC, et al. 2009. Down's syndrome suppression of tumour growth and the role of the calcineurin inhibitor DSCR1. Nature 459: 1126-1130.
3. Basille C, Frydman R, El Aly A, et al. 2009. Preimplantation genetic diagnosis: state of the art. Eur J Obstet Gynecol Reprod Biol 145: 9-13.
4. Cartier N, Hacein-Bey-Abina S, Bartholomae CC, et al. 2009. Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy. Science 326: 818-823.
5. Chan J, Kumar S, Fisk NM. 2008. First trimester embryo-fetoscopic and ultrasound-guided fetal blood sampling for ex vivo viral transduction of cultured human fetal mesenchymal stem cells. Hum Reprod 23: 2427-2437.
6. Chan J, O'Donoghue K, de la Fuente J, et al. 2005. Human fetal mesenchymal stem cells as vehicles for gene delivery. Stem Cells 23: 93-102.
7. Chan J, Waddington SN, O'Donoghue K, et al. 2007. Widespread distribution and muscle differentiation of human fetal mesenchymal stem cells after intrauterine transplantation in dystrophic mdx mouse. Stem Cells 25: 875-884.
8. Chang WC, Hawkes EA, Kliot M, Sretavan DW. 2007. In vivo use of a nanoknife for axon microsurgery. Neurosurgery 61: 683-691 (discussion 691-2).
9. Dejneka NS, Surace EM, Aleman TS, et al. 2004. In utero gene therapy rescues vision in a murine model of congenital blindness. Mol Ther 9: 182-188.
10. DeLia JE, Rogers JG, Dixon JA. 1985. Treatment of placental vasculature with a neodymium-yttrium-aluminum-garnet laser via fetoscopy. Am J Obstet Gynecol 151: 1126-1127.
11. Flake AW, Roncarolo MG, Puck JM, et al. 1996. Treatment of X-linked severe combined immunodeficiency by in utero transplantation of paternal bone marrow. N Engl J Med 335: 1806-1810.
12. Gaspar HB, Parsley KL, Howe S, et al. 2004. Gene therapy of X-linked severe combined immunodeficiency by use of a pseudotyped gammaretroviral vector. Lancet 364: 2181-2187.
13. Gaylin W. 1972. The Frankenstein myth becomes a reality - we have the awful knowledge to make exact copies of human beings. New York Times Magazine SM12.
14. Goodnow CC. 1996. Balancing immunity and tolerance: deleting and tuning lymphocyte repertoires. Proc Natl Acad Sci U S A 93: 2264-2271.
15. Goodnow CC, Sprent J, Fazekas de St Groth B, Vinuesa CG. 2005. Cellular and genetic mechanisms of self tolerance and autoimmunity. Nature 435: 590-597.
16. Gotherstrom C. 2007. Immunomodulation by multipotent mesenchymal stromal cells. Transplantation 84: S35-S37.
17. Gotherstrom C, Ringden O, Tammik C, Zetterberg E, Westgren M, Le Blanc K. 2004. Immunologic properties of human fetal mesenchymal stem cells. Am J Obstet Gynecol 190: 239-245.
18. Gotherstrom C, Ringden O, Westgren M, Tammik C, Le Blanc K. 2003. Immunomodulatory effects of human foetal liver-derived mesenchymal stem cells. Bone Marrow Transplant 32: 265-272. (Pubitemid 36927077)
19. Guillot PV, Abass O, Bassett JH, et al. 2008. Intrauterine transplantation of human fetal mesenchymal stem cells from first trimester blood repairs bone and reduces fractures in osteogenesis imperfecta mice. Blood 111: 1717-1725.
20. Hacein-Bey-Abina S, Le Deist F, Carlier F, et al. 2002. Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy. N Engl J Med 346: 1185-1193.
21. Haynes BF, Scearce RM, Lobach DF, Hensley LL. 1984. Phenotypic characterization and ontogeny of mesodermal-derived and endocrine epithelial components of the human thymic micro-environment. J Exp Med 159: 1149-1168.
22. Hogg T, Sretavan DW. 2005. Controlling tiny multi-scale robots for nerve repair. AAAI 1286-1291.
23. Kass L. 1972. Making babies-the new biology and the 'old' morality. Public Interest 26: 18-56.
24. Kazazian HH Jr. 1999. An estimated frequency of endogenous insertional mutations in humans. Nat Genet 22: 130-130.
25. Kenyon S, Pike K, Jones DR, et al. 2008a. Childhood outcomes after prescription of antibiotics to pregnant women with spontaneous preterm labour: 7-year follow-up of the ORACLE II trial. Lancet 372: 1319-1327.
26. Kenyon S, Pike K, Jones DR, et al. 2008b. Childhood outcomes after prescription of antibiotics to pregnant women with preterm rupture of the membranes: 7-year follow-up of the ORACLE I trial. Lancet 372: 1310-1318.
27. Kuhn DE, Nuovo GJ, Terry AV Jr, et al. 2010. Chromosome 21- derived microRNAs provide an etiological basis for aberrant protein expression in human Down syndrome brains. J Biol Chem 285: 1529-1543.
28. Le Blanc K, Gotherstrom C, Ringden O, et al. 2005. Fetal mesenchymal stem-cell engraftment in bone after in utero transplantation in a patient with severe osteogenesis imperfecta. Transplantation 79: 1607-1614.
29. Liechty KW, MacKenzie TC, Shaaban AF, et al. 2000. Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep. Nat Med 6: 1282-1286.
30. Lo YM, Hjelm NM, Fidler C, et al. 1998. Prenatal diagnosis of fetal RhD status by molecular analysis of maternal plasma. N Engl J Med 339: 1734-1738. (Pubitemid 28555431)
31. Lo YM, Patel P, Wainscoat JS, Sampietro M, Gillmer MD, Fleming KA. 1989. Prenatal sex determination by DNA amplification from maternal peripheral blood. Lancet 2: 1363-1365. (Pubitemid 20002969)
32. Panaroni C, Gioia R, Lupi A, et al. 2009. In utero transplantation of adult bone marrow decreases perinatal lethality and rescues the bone phenotype in the knockin murine model for classical, dominant osteogenesis imperfecta. Blood 114: 459-468.
33. Reay DP, Bilbao R, Koppanati BM, et al. 2008. Full-length dystrophin gene transfer to the mdx mouse in utero. Gene Ther 15: 531-536.
34. Roybal JL, Santore MT, Flake AW. 2009. Stem cell and genetic therapies for the fetus. Semin Fetal Neonatal Med 15: 46-51.
35. Savulescu J. 2002. Education and debate: Deaf lesbians, "designer disability," and the future of medicine. BMJ 325: 771-773.
36. Senat MV, Deprest J, Boulvain M, Paupe A, Winer N, Ville Y. 2004. Endoscopic laser surgery versus serial amnioreduction for severe twin-to-twin transfusion syndrome. N Engl J Med 351: 136-144.
37. Seppen J, van der Rijt R, Looije N, van Til NP, Lamers WH, Oude Elferink RP. 2003. Long-term correction of bilirubin UDPglucuronyltransferase deficiency in rats by in utero lentiviral gene transfer. Mol Ther 8: 593-599.
38. Skinner MK, Manikkam M, Guerrero-Bosagna C. 2010. Epigenetic transgenerational actions of environmental factors in disease etiology. Trends Endocrinol Metab 21: 214-222.
39. Slonim DK, Koide K, Johnson KL, et al. 2009. Functional genomic analysis of amniotic fluid cell-free mRNA suggests that oxidative stress is significant in Down syndrome fetuses. Proc Natl Acad Sci U S A 106: 9425-9429.
40. Sprent J. 1995. Central tolerance of T cells. Int Rev Immunol 13: 95-105.
41. Takahama Y. 2006. Journey through the thymus: stromal guides for T-cell development and selection. Nat Rev Immunol 6: 127-135. (Pubitemid 43361588)
42. Waddington SN, Nivsarkar MS, Mistry AR, et al. 2004. Permanent phenotypic correction of hemophilia B in immunocompetent mice by prenatal gene therapy. Blood 104: 2714-2721.
43. Wadman M. 1999. Gene therapy pushes on, despite doubts. Nature 397: 94-94.
44. Weatherall DJ. 2006. The Use of Non-Human Primates in Research. Academy of Medical Sciences: London.
45. Wengler GS, Lanfranchi A, Frusca T, et al. 1996. In-utero transplantation of parental CD34 haematopoietic progenitor cells in a patient with X-linked severe combined immunodeficiency (SCIDXI). Lancet 348: 1484-1487.
46. Westgren M, Ringden O, Bartmann P, et al. 2002. Prenatal T-cell reconstitution after in utero transplantation with fetal liver cells in a patient with X-linked severe combined immunodeficiency. Am J Obstet Gynecol 187: 475-482.
47. Westgren M, Ringden O, Eik-Nes S, et al. 1996. Lack of evidence of permanent engraftment after in utero fetal stem cell transplantation in congenital hemoglobinopathies. Transplantation 61: 1176-1179.
48. Zhang ZY, Teoh SH, Chong MS, et al. 2009. Superior osteogenic capacity for bone tissue engineering of fetal compared with perinatal and adult mesenchymal stem cells. Stem Cells 27: 126-137.